Navigation Links
Jazz Pharmaceuticals Announces Third Quarter 2012 Results
Date:11/8/2012

justed information is included with this press release.

Revenues and Product SalesTotal revenues for the quarter ended September 30, 2012 were $175.5 million, including net sales, royalties and contract revenues, but excluding the $8.1 million of net sales attributable to the divested women's health business that were reported separately as discontinued operations.  

A significant increase in total net sales for the third quarter of 2012 over the prior year third quarter resulted from the addition of net sales from the expanded product portfolio acquired in the Azur Pharma and EUSA Pharma transactions, as well as continued growth in net sales of Xyrem® (sodium oxybate) oral solution.Net sales from continuing operations for the third quarter of 2012 included:

  • Xyrem:  Net sales of Xyrem increased by 64% to $102.6 million for the third quarter of 2012, compared to net sales of $62.5 million in the third quarter of 2011. During the third quarter of 2012, the average number of active Xyrem patients was approximately 10,200.
  • Erwinaze/Erwinase: Worldwide net sales of Erwinaze®/Erwinase® (asparaginase Erwinia chrysanthemi) were $31.7 million.  Erwinaze was approved by the U.S. FDA in November 2011.
  • Prialt:  Third quarter 2012 net sales of Prialt® (ziconotide) intrathecal infusion were $5.4 million, compared to $5.0 million in the prior year quarter on a pro forma basis.
  • Psychiatry Products:  Net sales of the company's psychiatry products, including once-daily Luvox CR® (fluvoxamine maleate), FazaClo® (clozapine, USP) HD and FazaClo LD, were $21.0 million for the third quarter of 2012.  Net sales of these products in the prior year quarter were $19.7 million on a pro forma basis.
  • Other:  Net sales of other products for the third
    '/>"/>

  • SOURCE Jazz Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Harwood Feffer LLP Announces Investigation of DUSA Pharmaceuticals, Inc.
    2. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
    3. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
    4. Savient Pharmaceuticals Reports Third Quarter 2012 Financial Results
    5. Genoa Pharmaceuticals announces $1.2M Financing
    6. Inovio Pharmaceuticals Reports 2012 Third Quarter Financial Results
    7. Arisaph Pharmaceuticals Reports Positive Results From Two Safety Clinical Trials For Its Niacin Analog (ARI-3037MO)
    8. Oramed Pharmaceuticals to Present at the 12th Annual Diabetes Technology Society Meeting in Bethesda, MD, Nov 8-10, 2012
    9. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
    10. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    11. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... WASHINGTON and NEW YORK ... 2014 As the leading distributor of market ... a new research report by IQ4I Research and Consultancy ... To learn more about IQ4I Research visit: ... Active Pharmaceutical Ingredients Global Market – Forecast ...
    (Date:11/26/2014)... 25, 2014 Reinforcing its commitment to enabling ... PHG AEX: PHIA) today announced 510(k) ... for its IQon Spectral CT , presenting an ... technology adds a new dimension to Computed Tomography (CT) ... characterize structures based on their material content within a ...
    (Date:11/26/2014)... Pa. , Nov. 25, 2014  Unilife Corporation ... of injectable drug delivery systems, today announced that its ... to present at the Piper Jaffray 26th Annual Healthcare ... a.m. EST on Tuesday, December 2, 2014. ... Internet as a "live" listen only Webcast. To listen, ...
    Breaking Medicine Technology:MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 2MarketResearch.com: Active Pharmaceutical Ingredient Market to Reach $175 Billion by 2020 Says IQ4I Report 3Philips receives FDA 510(k) clearance for IQon Spectral CT 2Philips receives FDA 510(k) clearance for IQon Spectral CT 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
    (Date:11/27/2014)... 28, 2014 One of the ... The market for implant dentistry comprises dental implants ... global market for dental care is bifurcated into ... dental equipment segment is composed of large equipment. ... at: http://www.researchmoz.us/global-dental-market-report-2014-edition-report.html , The worldwide dental ...
    (Date:11/27/2014)... Today, Digital-Signage-China.com adds 2 new items to its collection ... media player promotion for Dec. 2014. , The CEO ... in April, and this promotion will help to expand our ... models on our website, she/he can contact us with special ... models come in the latest designs, and they actually are ...
    (Date:11/27/2014)... Turks and Caicos Islands; BWI (PRWEB) November 28, 2014 ... for the Tuscany Resort in the Turks & Caicos. ... resorts by TripAdvisor in Providenciales, is announcing a few ... three bedroom villa rentals. And they are offering ... resort. , Additionally, The Tuscany, is having a ...
    (Date:11/27/2014)... 27, 2014 According to a recent ... looking to break into the surgical robotics market ... other than the MIS field dominated by Intuitive. These ... U.S. surgical robotics market by 2020. , “The ... Kamran Zamanian, CEO and President of iData. “System sales ...
    (Date:11/27/2014)... Blood-borne pathogens raise the risk of spreading ... in place to counter this. However, it doesn’t seem ... with menstrual blood are taken as seriously. , ... way to handle tampons and menstrual pads while also ... , He then created a prototype of the Sani-M, ...
    Breaking Medicine News(10 mins):Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 2Health News:Dental Market Research Report 2014 - Global Industry Size, Share, Trends, Growth, Retail Sales Value and Forecast by Researchmoz.us 3Health News:Digital-Signage-China.com Offers Big Discounts On Its New Digital Signage Media Players 2Health News:The Tuscany on Grace Bay, Top-Rated TripAdvisor Resort in the Turks & Caicos Islands, Offers Special Pre-Christmas & January 2015 Promotions! 2Health News:U.S. Robotic Surgery Market Set to Diversify and Grow: Intuitive Surgical’s ‘da Vinci’ Robot Revenues to Increasingly Rely On Procedures and Services 2
    ... PHILADELPHIA A research team led by Nancy Speck, ... Perelman School of Medicine at the University of Pennsylvania, ... of hematopoietic (blood) stem cells (HSCs) in the developing ... from engineered precursors., Because HSCs, found in the bone ...
    ... FOR DEC. 9, 2011] The investigation of a 2009 ... (STEC), an important cause of bacterial gastrointestinal illness, led ... Published in Clinical Infectious Diseases and ... offers recommendations for prevention, including a stronger message for ...
    ... ANTONIO -- Precisely quantifying the amount of three different ... linked to breast cancer , did not predict ... Cancer with Herceptin, say Mayo Clinic researchers. HER2-positive ... human epidermal growth factor receptor 2 that promotes cancer ...
    ... quarter century of work in Malawi, a Michigan State ... MRI scans on children newly diagnosed with cerebral malaria ... Michael Potchen, an associate professor in the Department ... from the Dana Foundation, a private philanthropic organization supporting ...
    ... may help personalize pain medication management for sickle cell ... Dr. Cheedy Jaja, a nurse research scientist and ... National Institutes of Health grant to determine if variations ... opioids could help physicians manage sickle cell pain. ...
    ... blood test with other factors including the size of the ... up to one-quarter of men avoid biopsies and the risks ... team says. Writing in a study published online by ... G. Sanda, MD, Director of the Prostate Center at Beth ...
    Cached Medicine News:Health News:Penn study unlocks origins of blood stem cells 2Health News:Ready-to-bake cookie dough not ready-to-eat, study of E. coli outbreak finds 2Health News:Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer 2Health News:Uncovering how cerebral malaria damages the brain 2Health News:Study probes genetic link to sickle cell pain management 2Health News:Study probes genetic link to sickle cell pain management 3Health News:Study probes genetic link to sickle cell pain management 4Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 2Health News:PSA testing, combined with other relevant patient data can reduce unnecessary prostate biopsies 3
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: